Can Antibacterial Agent in Sutures Reduce SSIs?

J&J’s Ethicon, has been talking about its triclosan-coated sutures at international infection prevention and control event.


SSIs can be a serious complication of surgery, and are becoming the most common healthcare-associated infections, increasing morbidity and mortality rates among affected patients.

Ethicon makes so-called “Plus” Sutures, the only triclosan-coated sutures available that carry both CE and FDA certification. These sutures have been shown to inhibit colonization of the suture strand by bacteria commonly associated with SSIs. As such the company is pointing to 2016 World Health Organization guidance that suggests the use of triclosan-coated sutures in all types of surgery to reduce the incidence of SSI.

Ethicon has joined leading wound closure specialists to discuss recommendations to ease the burden of surgical site infections (SSIs) on patients and costs to healthcare systems across Europe, Middle East and Africa. The meeting was held  at the fourth International Consortium for Prevention & Infection Control (ICPIC) conference in Geneva, Switzerland.

Investigator comments

Speaking at the event, Professor Leaper, Professor of Clinical Sciences at the University of Huddersfield commented: “There are many reasons why we must act urgently to limit the incidence of surgical site infections. Not only do they have a significant impact on patients in terms of delayed wound healing, increased need for further surgery and longer hospital stays, but prescribing antibiotics to combat surgical site infections contributes to the growing problem of anti-microbial resistance.”

Company comments

Silvia De Dominicis, Ethicon Franchise Vice President for EMEA stated; “We want to see surgical site infections drastically reduced to relieve unnecessary suffering and reduce the associated costs for healthcare systems. We believe that all possible measures must be taken to help patients avoid SSIs and we are dedicated to partnering with the healthcare community to raise awareness, review the latest advancements and implement tactics to address this critical issue.”

Source: Ethicon

Share your thoughts

Your email address will not be published. Required fields are marked *